Title
Category
Credits
Event date
Cost
  • Patient Centered Care
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • CTR
  • NCPD/CNE
  • Participation
$0.00
Testicular cancer is the most common cancer in young men. We will discuss different aspects of this cancer from diagnosis, treatment options, and post-treatment survivorship.
  • Research to Practice
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • CTR
  • NCPD/CNE
  • Participation
$0.00
This lecture will review some of the new drugs recently FDA approved for management of lymphoma such as CAR-T therapy for relapsed/refractory Mantle Cell Lymphoma or follicular lymphoma. For rel/ref DLBCL, polatuzumab vedotin in combination with bendamustine and rituximab as well as tafasitamab plus lenalidomide have been approved in recent years. We will review the data and outcomes.
  • Patient Centered Care
  • Southeastern American Indian Cancer Health Equity Partnership
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • CTR
  • NCPD/CNE
  • Participation
$0.00
Ronny Bell, PhD, MS, and Marc Emerson, PhD, MPH, in this collaborative session will provide context regarding the cancer disparities and efforts to address these disparities for American Indians and Alaska Natives across the US. Dr. Bell will provide context for understanding and addressing cancer disparities among American Indians in North Carolina.
  • AMA PRA Category 1 Credit
  • AMA PRA Category 1 Credit™ - Non-physician
  • Participation
$0.00
Course DescriptionIn this talk, Kaitlin Morrison, PhD will take to you about the 3 major reasons that protocols requirement amendments and how to avoid them.
  • AMA PRA Category 1 Credit
  • AMA PRA Category 1 Credit™ - Non-physician
  • Participation
$0.00
Course DescriptionIn this talk, Kaitlin Morrison, PhD takes you through the what you should consider when doing preclinical, manufacturing and clinical work involving Chimeric Antigen Receptor (CAR) T cells.
  • AMA PRA Category 1 Credit
  • AMA PRA Category 1 Credit™ - Non-physician
  • Participation
$0.00
Course DescriptionIn this talk, Kaitlin Morrison, PhD will take you through how to develop and implement a quality management plan to ensure you get good clinical trial results on your investigator-initiated trial (IIT).
  • Participation
$0.00
Behind cardiovascular disease, Cancer is the 2nd leading cause of deaths in the United States. What causes Cancer? Why have we not cured Cancer yet?
  • Patient Centered Care
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • CTR
  • NCPD/CNE
  • Participation
$0.00
In this webinar, we will discuss the definition and use of electronic patient-reported outcomes (ePROs) and mobile health technology in optimizing postoperative cancer care.
  • Research to Practice
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • CTR
  • NCPD/CNE
  • Participation
$0.00
Oral chemotherapy is becoming increasingly common in treatment of various malignancies. Although oral oncolytics are extremely beneficial for patients, they also present unique challenges for patients and providers alike. Implementing oral chemotherapy often requires a multidisciplinary approach. This lecture will discuss several considerations for oral chemotherapy such as prescribing, patient education, adherence, medication access, cost and insurance authorization, monitoring, supportive care, and more.
  • Advanced Practice Provider
  • Participation
$0.00
This lecture will provide information to identify current and future cancer survivorship trends, use a framework to analyze survivors’ risks for long-term late effects and identify unmet needs, describe the APPs role in delivering follow-up/survivorship care and list survivorship resources.

Pages